The eRulemaking Program
10/02/2025 | Press release | Distributed by Public on 10/02/2025 13:33
Bulk Manufacturer-Cargill Incorp(2025-19317)DEA1598
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1598]
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 1, 2025. Such persons may also file a written request for a hearing on the application on or before December 1, 2025.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on August 13, 2025, Cargill, Incorporated, 17540 Monroe Wapello Road, Eddyville, Iowa 52553, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
| Controlled substance | Drug code | Schedule |
| Gamma Hydroxybutyric Acid | 2010 | I |
The company plans to bulk manufacture butanediol as a raw material for industrial and consumer products. Gamma Hydroxybutyric Acid will be manufactured as a byproduct and an impurity waste of butanediol. The company does not plan to bulk manufacture this drug. No other activity for this drug code is authorized for this registration.
Justin Wood,
Acting Deputy Assistant Administrator.
[FR Doc. 2025-19317 Filed 10-1-25; 8:45 am]
BILLING CODE 4410-09-P
The eRulemaking Program published this content on October 02, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 19:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]